- Home
- ORGO vs STK Comparison
ORGO vs STK Comparison
Compare ORGO & STK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- STK
- Stock Information
- Founded
- ORGO 1985
- STK 2009
- Country
- ORGO United States
- STK United States
- Employees
- ORGO N/A
- STK N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- STK Investment Managers
- Sector
- ORGO Health Care
- STK Finance
- Exchange
- ORGO Nasdaq
- STK Nasdaq
- Market Cap
- ORGO 533.9M
- STK 434.6M
- IPO Year
- ORGO N/A
- STK N/A
- Fundamental
- Price
- ORGO $3.11
- STK $29.82
- Analyst Decision
- ORGO Buy
- STK
- Analyst Count
- ORGO 2
- STK 0
- Target Price
- ORGO $5.50
- STK N/A
- AVG Volume (30 Days)
- ORGO 2.1M
- STK 38.2K
- Earning Date
- ORGO 05-08-2025
- STK 01-01-0001
- Dividend Yield
- ORGO N/A
- STK 6.60%
- EPS Growth
- ORGO N/A
- STK N/A
- EPS
- ORGO N/A
- STK N/A
- Revenue
- ORGO $458,760,000.00
- STK N/A
- Revenue This Year
- ORGO $3.31
- STK N/A
- Revenue Next Year
- ORGO $12.50
- STK N/A
- P/E Ratio
- ORGO N/A
- STK N/A
- Revenue Growth
- ORGO 5.35
- STK N/A
- 52 Week Low
- ORGO $2.17
- STK $24.95
- 52 Week High
- ORGO $6.71
- STK $34.31
- Technical
- Relative Strength Index (RSI)
- ORGO 31.37
- STK 67.58
- Support Level
- ORGO $2.88
- STK $27.85
- Resistance Level
- ORGO $5.55
- STK $28.75
- Average True Range (ATR)
- ORGO 0.39
- STK 0.46
- MACD
- ORGO -0.23
- STK 0.33
- Stochastic Oscillator
- ORGO 7.68
- STK 93.65
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About STK Columbia Seligman Premium Technology Growth Fund Inc
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.